OTTAWA, CANADA--(Marketwire - November 21, 2008) - Chemaphor Inc. (TSX VENTURE: CFR), a biotechnology research and development company today announced plans to seek financing of approximately $1 million, subject to demand for subscriptions, by way of a non-brokered equity private placement. The definitive terms, total amount and pricing of the private placement will be determined through consultation with Chemaphor's advisors and potential subscribers.
